Please ensure Javascript is enabled for purposes of website accessibility

Foreign Firms Land 3 Pentagon Defense Contracts

By Rich Smith – Mar 4, 2014 at 11:16PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Subsidiaries of Hikma Pharma, Bayer, and Finmeccanica all win contracts.

After taking Monday off, the Department of Defense's acquisitions specialists got back to work today, awarding 18 separate defense contracts Tuesday, worth a total of $4.22 billion.

Foreign-listed companies made out particularly well in this latest round of contract awards, with contracts being awarded to:

  • Hikma Pharmaceuticals (HIK -0.33%) subsidiary West-Ward Pharmaceuticals, which was awarded the first of nine possible one-year long "option" exercises on a contract to supply "various pharmaceutical products" to the U.S. Army, Navy, Air Force, and Marine Corps. This option exercise will be worth up to $70.9 million to Hikma and will run through at least Feb. 26, 2015.
  • Bayer AG (BAYR.Y 0.44%) subsidiary Bayer Healthcare Pharmaceuticals, which won a similar option-year extension (the second of seven possible) on a contract to supply "various pharmaceutical products" to the U.S. Army, Navy, Air Force, Marine Corps, and federal civilian agencies. The value of Bayer's option is put at up to $49.4 million, and its contract will now run through at least March 5, 2015.
  • DRS Tactical Systems, a subsidiary of Italy's Finmeccanica (FINMY -0.85%), which won a $12.6 million firm-fixed-price contract to supply the U.S. Army with improved platform integration kits for M777A2 115mm and M119A3 105mm howitzers. Deliver is due Feb. 27, 2019.

Rich Smith and The Motley Fool have no position in any of the stocks mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.